
Select Variant: 1
Support your dog's cardiovascular function and improve their quality of life with Vivaldis Ben-Spiro Chewable Tablets, available online at PetMitra. Formulated by Vivaldis Animal Health, Ben-Spiro introduces an FDA-approved therapeutic concept to Indian pet care, combining two frontline cardiovascular agents—Spironolactone and Benazepril Hydrochloride—into a single, palatable chewable tablet. When dogs suffer from Congestive Heart Failure (CHF) secondary to degenerative mitral valve disease or valvular insufficiency, the body's Renin-Angiotensin-Aldosterone System (RAAS) becomes chronically overactive. This causes arterial constriction, fluid retention (pulmonary edema/ascites), and dangerous cardiac remodeling (myocardial fibrosis). Ben-Spiro provides complete RAAS blockade: Benazepril inhibits Angiotensin-Converting Enzyme (ACE) to dilate blood vessels and decrease vascular resistance, while Spironolactone blocks aldosterone receptors to prevent potassium loss, control fluid retention, and halt myocardial fibrosis. Together, they ease cardiac workload, relieve respiratory fatigue, and extend clinical comfort in dogs with heart disease.